Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROMIPLOSTIM Cause Condition aggravated? 45 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Condition aggravated have been filed in association with ROMIPLOSTIM (Nplate). This represents 0.6% of all adverse event reports for ROMIPLOSTIM.

45
Reports of Condition aggravated with ROMIPLOSTIM
0.6%
of all ROMIPLOSTIM reports
7
Deaths
23
Hospitalizations

How Dangerous Is Condition aggravated From ROMIPLOSTIM?

Of the 45 reports, 7 (15.6%) resulted in death, 23 (51.1%) required hospitalization, and 3 (6.7%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROMIPLOSTIM. However, 45 reports have been filed with the FAERS database.

What Other Side Effects Does ROMIPLOSTIM Cause?

Off label use (1,027) Platelet count decreased (892) Platelet count abnormal (703) Drug ineffective (513) Thrombocytopenia (369) Headache (359) Death (356) Product storage error (344) Fatigue (251) Circumstance or information capable of leading to medication error (238)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which ROMIPLOSTIM Alternatives Have Lower Condition aggravated Risk?

ROMIPLOSTIM vs ROMOSOZUMAB ROMIPLOSTIM vs ROMOSOZUMAB-AQQG ROMIPLOSTIM vs ROPEGINTERFERON ALFA-2B-NJFT ROMIPLOSTIM vs ROPINIROLE ROMIPLOSTIM vs ROPIVACAINE

Related Pages

ROMIPLOSTIM Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated ROMIPLOSTIM Demographics